Literature DB >> 1485469

Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.

I Tkác1, R Tkácová, M Takác, J Lazúr.   

Abstract

Some hematologic parameters have been measured in 80 patients with Type 2 diabetes mellitus. The patients were divided into three groups: (a) proximal (pelvic and femoral) lower limb macroangiopathy; (b) distal (tibial) macroangiopathy; and (c) control group of diabetics without lower limb macroangiopathy. Mean hemoglobin, hematocrit and fibrinogen values were significantly higher in both the proximal and distal macroangiopathy groups in comparison with the controls. On the other hand, mean leucocyte and platelet counts were significantly elevated only in the proximal macroangiopathy group. Significant correlations were observed in univariate and multivariate analyses between blood fibrinogen concentration and pressure indices expressing severity of lower limb macroangiopathy (ankle/thigh, ankle/arm). In summary, increased levels of hematologic parameters contributing to the increase of whole blood viscosity were observed in Type 2 diabetics with arteriosclerosis obliterans. The observed relationship between fibrinogen concentration and severity of arteriosclerosis obliterans could be an evidence in favor for fibrinogen lowering therapy in this pathologic condition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1485469

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  2 in total

1.  Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus.

Authors:  Ivan Tkác; Ján Salagovic; Miriam Kozárová; Martin Javorský; Ruzena Tkácová; Ivan Kalina
Journal:  Wien Klin Wochenschr       Date:  2003-12-15       Impact factor: 1.704

2.  Anaemia and kidney dysfunction in Caribbean type 2 diabetic patients.

Authors:  Chidum E Ezenwaka; Altheia Jones-Lecointe; Emeka Nwagbara; Dawn Seales; Fidelis Okali
Journal:  Cardiovasc Diabetol       Date:  2008-08-27       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.